Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid May 10, 2015
Anavex to Present on Sigma-1 Receptors at the World Orphan Drug Congress and to Reveal New Epilepsy Data at Antiepileptic Drug Trials XIII Conference April 23, 2015
Anavex Encouraged by New Scientific Data Revealing Positive Role of Sigma-1 Receptors in Brain Injuries April 7, 2015
Anavex Presents Positive Results for Both ANAVEX 2-73 and ANAVEX 3-71 in Alzheimer’s Models at 2015 AD/PD™ Conference March 23, 2015
Anavex Appoints Epilepsy and Clinical Trial Methodology Expert to Scientific Advisory Board March 12, 2015
Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries March 11, 2015
Anavex Appoints Scientific Advisory Board Member with Expertise in Protein Misfolding Neurodegenerative Diseases March 5, 2015
ANAVEX 2-73 Could Prevent Alzheimer’s Disease in Addition to Modifying and Treating Symptoms February 25, 2015
